Search Results

Displaying Results 1076-1100 of 2612 "'DNA'"

Jan 08, 2026, 17:25 ET SAMI Chat from eschbach Wins 2026 IoT Breakthrough Award for AI Innovation

actionable insights. The technology helps improve efficiency, ensure compliance and advance operational excellence."Innovation is etched into the DNA of eschbach, and winning the IoT Breakthrough Award for SAMI Chat is powerful validation that we are successfully pushing the boundaries of what AI can

More news about: eschbach


Jan 08, 2026, 16:30 ET Illumina Appoints Dr. Eric Green as Chief Medical Officer

IlluminaIllumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in

More news about: Illumina, Inc.


Jan 08, 2026, 12:00 ET The Board of Medicine Launches Membership Program Expanding Access to Emerging Medical Knowledge

Frontiers in Psychiatry: Pilot study suggests DNA methylation of the glucocorticoid receptor gene (NR3C1) is associated with MDMA-assisted therapy treatment response for severe PTSD; and

More news about: The Board of Medicine


Jan 08, 2026, 11:39 ET Bionova Scientific and Syenex Forge Strategic Alliance to Expand Access to High-Quality Plasmid DNA for Advanced Therapies

Bionova's high-titer, high-purity plasmid DNA manufacturing processes, the platform delivers robust, reproducible plasmids suitable for use in all genetic medicine formats, including LVV production or for mRNA manufacturing as DNA templates.Under the agreement, Bionova

More news about: Bionova Scientific


Jan 08, 2026, 11:00 ET DELFI Diagnostics Appoints Cindy Soriano as Chief Financial Officer and Announces Participation in 44th Annual J.P. Morgan Healthcare Conference

discovery that cancer cells are more chaotic than normal cells and, when they die, leave behind tell-tale patterns and characteristics of cell-free DNA (cfDNA) fragments in the blood. The DELFI platform applies advanced machine-learning technology to whole-genome sequencing data to assess individuals'

More news about: DELFI Diagnostics


Jan 08, 2026, 10:05 ET Aily Labs Launches "Lead Boldly" - a New Call for Decisive Leadership in the AI Era

and Samuel Abrahams, a BAFTA-nominated English film director who has written and directed across drama, documentary, and commercials. True to Aily's AI-first DNA, the campaign was created using the latest AI-enabled virtual production techniques; AI, telling the story of AI-driven leadership.Learn more

More news about: Aily Labs


Jan 08, 2026, 09:59 ET Aily Labs Launches "Lead Boldly" - a New Call for Decisive Leadership in the AI Era

and Samuel Abrahams, a BAFTA-nominated English film director who has written and directed across drama, documentary, and commercials. True to Aily's AI-first DNA, the campaign was created using the latest AI-enabled virtual production techniques; AI, telling the story of AI-driven leadership.Learn more

More news about: Aily Labs


Jan 08, 2026, 08:15 ET MDA SPACE SELECTED BY MISSILE DEFENSE AGENCY FOR SHIELD PROGRAM

vision into an achievable mission – bringing to bear a one-of-a-kind mix of experience, engineering excellence and wide-eyed wonder that's been in our DNA since day one. For those who dream big and push boundaries on the ground and in the stars to change the world for the better, we'll take you there. For

More news about: MDA Space


Jan 08, 2026, 08:02 ET EPAM and Cursor Announce Strategic Partnership to Build and Scale AI-Native Teams for Global Enterprises

organizations must embrace AI-native approaches that drive productivity and sustainable transformation. Cursor's rapid AI innovation and EPAM's engineering DNA enable clients to adopt next-generation workflows — delivering measurable improvements in efficiency, adoption rates and return on investment. Together,

More news about: EPAM Systems, Inc.


Jan 08, 2026, 08:00 ET Factorial Biotechnologies and Honeycomb Biotechnologies Partner to Deliver High-Throughput, Instrument-Free Single-Cell DNA Sequencing

preparation technology, researchers can now extend these capabilities to comprehensive single-cell DNA analysis and multi-omic profiling."Extending the HIVE platform to instrument-free single-cell DNA sequencing will accelerate discoveries in somatic mosaicism, tumor evolution, and gene editing by

More news about: Factorial Biotechnologies


Jan 08, 2026, 08:00 ET Klotho Neurosciences to Present at the Biotech Showcase 2026

ALS, Alzheimer's disease, and Parkinson's disease. The Company's current portfolio consists of its proprietary cell and gene therapy programs using DNA and RNA as therapeutics and genomics-based diagnostic assays. Klotho is managed by a team of individuals and advisors who are highly experienced in biopharmaceutical

More news about: Klotho Neurosciences, Inc.


Jan 08, 2026, 08:00 ET Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016

next-generation ADC programs leverage Whitehawk's advanced ADC technology platform consisting of a highly stable yet cleavable linker that delivers a DNA Topoisomerase I (TOP1) inhibitor payload. Whitehawk expects to report initial clinical data from these trials in early 2027."These are important

More news about: Whitehawk Therapeutics, Inc.


Jan 07, 2026, 14:00 ET RFU Helix 51 Incubator Company Receives Illinois Innovation Voucher Grant Award for Cancer-Drug Development

embodies the spirit of inquiry and excellence modeled by its namesake Dr. Rosalind Franklin, whose Photo 51 was crucial to solving the structure of DNA. Recognized for its research in the areas of neuroscience, brain related diseases, inherited disorders, diabetes, obesity, and gait and balance, the

More news about: Rosalind Franklin University of Medicine and Science


Jan 07, 2026, 13:00 ET Urban to Adventure: Heybike's Seven-Model CES Showcase Covers Every Rider's Dream

best-value dirt bike to riders who want to make their own lane. Delivering maximum value and making riding purely enjoyable has always been in Heybike's DNA, and Villain is the brand's next step beyond eBikes to unlock a bolder, more playful riding culture.Villain is a ready to roll and easy to mod

More news about: Heybike


Jan 07, 2026, 12:36 ET Spoločnosť CooperVision uvádza na trh mäkké kontaktné jednodňové šošovky MyDay® MiSight® 1 day na kontrolu krátkozrakosti

kontrolovať zhoršovanie krátkozrakosti.◊10-12„Táto inovácia prináša „stálu" kontrolu krátkozrakosti – deti profitujú z liečby počas celého dňa jednoducho tým, že nosia kontaktné šošovky," povedala Jennifer Lambertová, viceprezidentka pre liečbu krátkozrakosti a starostlivosť o rohovku v spoločnosti

More news about: CooperVision, Inc.


Jan 07, 2026, 09:07 ET KilgourMD Announces Exclusive Partnership With N1 Life to Bring Peptide-Based Delivery Technology to Scalp Health

applies these technologies to a diverse R&D program, spanning oncology to dermatology diseases, using payloads ranging from small molecules to RNA/DNA. Their mission is to enhance targeted drug delivery, ensuring that treatments reach their intended cells and tissues effectively, thus opening new

More news about: KilgourMD


Jan 07, 2026, 09:00 ET OLAY Debuts New Regenerist Micro-Sculpting Cream with Triple Collagen Peptide, Joined by Ambassador Sarah Michelle Gellar

ensuring its formulas deliver accessible, high-performance results for every skin type and tone.This commitment has long been part of OLAY's DNA: when women feel confident in their skin, they can face anything.The new OLAY Regenerist Micro-Sculpting Cream is available at OLAY.com

More news about: OLAY


Jan 07, 2026, 08:50 ET ProRx Pharma Redefines NAD+ Delivery with New Oral System for Medical Clinics

NAD+ formulation. This advancement introduces a new, convenient option for medical clinics and wellness providers seeking to support cellular energy, DNA repair, and long-term vitality in their patients without relying on daily injectable protocols.

More news about: ProRx Pharma


Jan 07, 2026, 07:52 ET TCL Unveils Breakthrough SQD-Mini LED Display Technology and AI-Driven Smart Living Innovations at CES 2026

sustainability and artistic accessibility.Demonstrating a long-term commitment to the planet, the TCLGreen initiative is embedded in the company's DNA, aiming to inspire greatness by creating a greener world for all while enhancing personal wellbeing. A standout achievement of this initiative is the

More news about: TCL


Jan 07, 2026, 07:33 ET TCL Unveils Breakthrough SQD-Mini LED Display Technology and AI-Driven Smart Living Innovations at CES 2026

sustainability and artistic accessibility.Demonstrating a long-term commitment to the planet, the TCLGreen initiative is embedded in the company's DNA, aiming to inspire greatness by creating a greener world for all while enhancing personal wellbeing. A standout achievement of this initiative is the

More news about: TCL


Jan 07, 2026, 00:21 ET Nebula Next Debuts at CES 2026, Accelerating Globalization Strategy

and product innovation experience in the intelligent hardware sector. This forms an organizational structure driven by a "Smart + Manufacturing" dual DNA.

More news about: Nebula Next


Jan 06, 2026, 16:37 ET Noninvasive prenatal screening could prevent permanent hearing loss in newborns

viruses and bacteria for free-floating fragments of DNA (called cell-free DNA) from CMV.They found CMV DNA in 2.1% (462) of the pregnancies studied. The researchers divided those patients' blood samples into four groups based on the amount of viral DNA detected, ranging from least to most. They validated

More news about: Association for Diagnostics & Laboratory Medicine (ADLM)


Jan 06, 2026, 16:04 ET Advances in maternal-fetal and neonatal diagnostics highlighted in special January issue of ADLM's Clinical Chemistry journal

leading cause of congenital hearing loss.  In the realm of molecular diagnostics, new research highlights developments made by sequencing the DNA of pediatric cancer patients and links specific sequences to tumor risk. A perspective article describes how CRISPR, a groundbreaking gene-editing technique,

More news about: Association for Diagnostics & Laboratory Medicine (ADLM)


Jan 06, 2026, 10:15 ET Wendy Buckley Joins PROACTIVE Real Estate Brokerage

perspective support the firm's focus on helping clients build long-term value and generational wealth through real estate.With her strong "hospitality DNA" and results-oriented mindset, Wendy Buckley strengthens PROACTIVE Real Estate's commitment to exceptional service, trusted expertise, and elevated client

More news about: PROACTIVE Real Estate


Jan 06, 2026, 10:01 ET Data Featuring Haystack MRD® from Quest Diagnostics to be Presented at the 2026 ASCO Gastrointestinal Cancers Symposium

-- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that data will be shared on circulating tumor DNA (ctDNA) minimal residual disease (MRD) testing during two poster presentations at the 2026 ASCO Gastrointestinal Cancers Symposium, being held January

More news about: Quest Diagnostics


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.